Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 324
Aptamer sequence: GGGAGGACGAUGCGGUCGUAUUAUCCGCUGCACGCCAGACGACUCGCCCGA
Target unique ID: P15209
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_315 C4-3 Protein NTRK2_MOUSE 2 nM 0.901 mM CaCl2, 0.493 mM MgCl2, 2.67 mM KCl, 1.47 mM KH2PO4 , 137.93 mM NaCl and 8.06 mM Na2HPO4 22752556
Structure information of aptamer
Aptamer Sequence: GGGAGGACGAUGCGGUCGUAUUAUCCGCUGCACGCCAGACGACUCGCCCGA
The optimal secondary structure in dot-bracket notation: (((.((.((.(((((.((.......))))))))))).((....)).)))..
The centroid secondary structure in dot-bracket notation: (((.((.((.(((((.((.......)))))))))))..........)))..
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_315 Description C4-3
Aptamer chemistry RNA Length 51 nt
GC content 64.7% Molecular weight 16,670.76 Da
Molarity of 1 μg/μl solution 59.99 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted binding
Sequence GGGAGGACGAUGCGGUCGUAUUAUCCGCUGCACGCCAGACGACUCGCCCGA
Applications Identification of aptamer-based agonists for a variety of cell-surface signaling receptors
Target information
Type Detail Type Detail
Uniprot ID P15209 Protein name BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB/GP95-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase)
Gene name(s) Ntrk2 Trkb Organism BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB/GP95-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase)
Status reviewed in uniprot database Length 821
Mass 92,133 Activity regulation The formation of active receptors dimers able to fully transduce the ligand-mediated signal, may be negatively regulated by the formation of inactive heterodimers with the non-catalytic isoforms
Involvement in disease N/A Catalytic activity Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-[protein]
PDB ID(s)
N/A
Function Receptor tyrosine kinase involved in the development and the maturation of the central and the peripheral nervous systems through regulation of neuron survival, proliferation, migration, differentiation, and synapse formation and plasticity.
Activity data
Interaction ID 324
Target type Protein
Target unique ID P15209
Activity 2 nM
Binding Conditions/Buffer

0.901 mM CaCl2, 0.493 mM MgCl2, 2.67 mM KCl, 1.47 mM KH2PO4 , 137.93 mM NaCl and 8.06 mM Na2HPO4

Assay

C4-3 is specifically internalized by TrkB-expressing HEK cells. TrkB-expressing or TrkB-negative HEK cells were incubated with 100 nM FAM-labeled C4-3 or control RNA for 1 h at 37 °C. Surface-bound RNA was stripped from the cells with a salt/acid wash, and then cells were fixed with formaldehyde, permeabilized, and labeled with anti-FAM and fluorescent secondary antibodies. A, TrkB-expressing HEK cells incubated with C4-3. B, HEK cells incubated with C4-3. C, TrkB-expressing HEK cells incubated with control RNA. Note evidence of C4-3 immunoreactivity signal within TrkB-expressing HEK cells [punctate (e.g., see arrows) and diffuse fluorescence in A] and signal absence in cells lacking TrkB (B). Signal detected with control RNA in TrkB-expressing HEK cells (C) provides a measure of nonspecific uptake of RNA molecules of the size of C4-3 in these cells

PubMed ID 22752556
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_131 RNA GGGAGGACGAUGCGGUCCUGUCGUCUGUUCGUCCCCAGACGACUCGCCCGA
80.39%
Apta_132 RNA GGGAGGACGAUGCGGCGUUUCCUCUGGUUCGUCCCCAGACGACUCGCCCGA
80.39%
Apta_133 RNA GGGAGGACGAUGCGGUGAGUCGUUCCCUUCGUCCCCAGACGACUCGCCCGA
80.39%
Apta_134 RNA GGGAGGACGAUGCGGGCCGUUGUUGUGUGCCGCCCCAGACGACUCGCCCGA
80.39%
Apta_135 RNA GGGAGGACGAUGCGGAUUCUGGUUACUGGCCGCCCCAGACGACUCGCCCGA 78.43%
Apta_130 RNA GGGAGGACGAUGCGGUGGUAGCGCGAUAUAGCGCUGGUAGGGUUGCCGGUGAUCAGACGACUCGCCCGA 66.67%
Apta_352 RNA GGGAGGACGAUGCGGUGGUCUCCCAAUUCUAAACUUUCUCCAUCGUAUCUGGGCAGACGACUCGCCCGA 66.67%
Apta_984 RNA GGGAGGACGAUGCGGCGUAUUGCGCGAGGAUUAUCCGCUCAUCGUUGUUGUUGUGCAGACGACUCGCCCGA 66.20%
Apta_129 RNA GGGAGGACGAUGCGGACACCGUUAAUCUGAGGCCCUGUCCUAUUCCUUCACGCCUCAGA 64.41%
Apta_305 RNA GGGAGGACGAUGCGGAUCGCCCUGAACCGGCCCAGCAGACUGCUGACGGCACGAUCCGCAUCGUCCUCCC 61.43%
Apta_399 RNA GGGAGGACGAUGCGGCAAACCAGCUAUUUCCUGAGGUACCCCGGCUCUCCAUGGCAGACGACUCGCUGAGGAUCCGAGA 59.49%
Apta_400 RNA GGGAGGACGAUGCGGAUACCAGCGAAUAACUCGCUGAGGAACCCGACUCACAAACAGACGACUCGCUGAGGAUCCGAGA 59.49%
Apta_396 RNA GGGAGGACGAUGCGGCAGUCUGCAUCGUAGGAAUCGCCACCGUAUACUUUCCCACCAGACGACUCGCUGAGGAUCCGAGA 58.75%
Apta_397 RNA GGGAGGACGAUGCGGAUACCAGGAUCACAUCCUGAGGAACCCCGGCUCCCAACCUCAGACGACUCGCUGAGGAUCCGAGA 58.75%
Apta_414 RNA GGGAGGACGAUGCGGCCGAUUAGAACUGGGCUGAGGCGUUCUGCAUUUCGGUGAUCAGACGACUCGCUGAGGAUCCGAGA 58.75%
Apta_415 RNA GGGAGGACGAUGCGGAAACUCAUCGGUAGCCUUCCUGCGGUCAGUCUAUUAGGACCAGACGACUCGCUGAGGAUCCGAGA 58.75%
Apta_398 RNA GGGAGGACGAUGCGGCUUUAAUCCUCGCACUCAGCGCGCAUCACCCUUGACAUCACAGACGACUCGCUGAGGAUCCGAGA 57.50%
Apta_660 RNA UGGGAGGAGUGCUGCUCUCCAGGCACUCUUGUUGCUCGGA 56.86%
Apta_467 RNA GGGAGGACGAUGCGGCAGUGCCCAACCGGAACAACAACCACCGGCGGCUCCUGCUCAGACGACUCGCUGAGGAUCCGAGA 56.25%
Apta_230 RNA GGGAGGACGAUGCGGGCGUGAAUGGUGUUGUGAGG 54.90%